VL

Vijay Laxmi Dinker

Director Director DIN 09133064
DIN 09133064 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Laxmi Dinker

Data last updated:

Vijay Laxmi Dinker was a Director at D-Cure Pharmaceuticals Private Limited (2022–2024) and Director at Erkin Healthcare Private Limited (from 2021). The companies operate in Pharma.

DIN 09133064
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2021
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20222015₹45.4 Lakh (FY 2024)Active
Erkin Healthcare Private Limited U33208UP2020PTC131102
Director02 Apr 20212020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Erkin Healthcare Private Limited
D-Cure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vijay Laxmi Dinker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Laxmi Dinker

Vijay Laxmi Dinker was first appointed on 02 Apr 2021 as Director at Erkin Healthcare Private Limited. The most recent appointment on record is 05 Jan 2022 at D-Cure Pharmaceuticals Private Limited.

Vijay Laxmi Dinker held 2 earlier board appointments: D-Cure Pharmaceuticals Private Limited (Director, 05 Jan 2022 to 14 Mar 2024); Erkin Healthcare Private Limited (Director, from 02 Apr 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available